1. Home
  2. PRTC vs CPAC Comparison

PRTC vs CPAC Comparison

Compare PRTC & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • CPAC
  • Stock Information
  • Founded
  • PRTC 2015
  • CPAC 1949
  • Country
  • PRTC United States
  • CPAC Peru
  • Employees
  • PRTC N/A
  • CPAC N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • CPAC Building Materials
  • Sector
  • PRTC Health Care
  • CPAC Industrials
  • Exchange
  • PRTC Nasdaq
  • CPAC Nasdaq
  • Market Cap
  • PRTC 414.6M
  • CPAC 436.7M
  • IPO Year
  • PRTC N/A
  • CPAC 2012
  • Fundamental
  • Price
  • PRTC $16.78
  • CPAC $5.60
  • Analyst Decision
  • PRTC Buy
  • CPAC Sell
  • Analyst Count
  • PRTC 1
  • CPAC 1
  • Target Price
  • PRTC $45.00
  • CPAC $6.00
  • AVG Volume (30 Days)
  • PRTC 2.5K
  • CPAC 7.4K
  • Earning Date
  • PRTC 04-30-2025
  • CPAC 04-28-2025
  • Dividend Yield
  • PRTC N/A
  • CPAC 8.92%
  • EPS Growth
  • PRTC N/A
  • CPAC 15.59
  • EPS
  • PRTC 0.21
  • CPAC 0.13
  • Revenue
  • PRTC $4,828,000.00
  • CPAC $545,786,617.00
  • Revenue This Year
  • PRTC $35.98
  • CPAC N/A
  • Revenue Next Year
  • PRTC $115.38
  • CPAC N/A
  • P/E Ratio
  • PRTC $7.47
  • CPAC $8.76
  • Revenue Growth
  • PRTC 44.98
  • CPAC 2.78
  • 52 Week Low
  • PRTC $13.30
  • CPAC $5.10
  • 52 Week High
  • PRTC $32.98
  • CPAC $6.65
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 45.09
  • CPAC 53.49
  • Support Level
  • PRTC $17.41
  • CPAC $5.20
  • Resistance Level
  • PRTC $17.55
  • CPAC $5.59
  • Average True Range (ATR)
  • PRTC 0.46
  • CPAC 0.13
  • MACD
  • PRTC 0.01
  • CPAC 0.02
  • Stochastic Oscillator
  • PRTC 40.40
  • CPAC 85.11

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

Share on Social Networks: